ArticleOncoimmunology2015

Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab.

Fan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.